HPP-P-C vs DRUG

Comparison between Hudson Pacific Properties Inc (HPP-P-C, Company) and Bright Minds Biosciences Inc (DRUG, Company).

5-Year PerformanceDRUG has outperformed HPP-P-C, delivering a return of +27.0% compared to -3.3%

HPP-P-C vs DRUG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	HPP-P-C(COMPANY)	DRUG(COMPANY)
Market Cap	$724M	$724M
Max Drawdown	69.84%	97.68%
Sharpe Ratio	0.17	1.67
5Y Beta	0.40	-0.76
Industry	N/A	Biotechnology
P/E Ratio	-0.99	-30.67
PEG Ratio	N/A	-0.08
5Y EPS CAGR	N/A	8.42%
Debt to Equity	0.00%	0.03%
Free Cash Flow Yield	16.71%	-2.01%
P/B Ratio	N/A	3.49

Market Cap

Winner

HPP-P-C

$724M

DRUG

$724M

Max Drawdown

Winner

HPP-P-C

69.84%

DRUG

97.68%

Sharpe Ratio

HPP-P-C

0.17

Winner

DRUG

1.67

5Y Beta

HPP-P-C

0.40

Winner

DRUG

-0.76

Industry

HPP-P-C

N/A

DRUG

Biotechnology

P/E Ratio

HPP-P-C

-0.99

Winner

DRUG

-30.67

PEG Ratio

HPP-P-C

N/A

DRUG

-0.08

5Y EPS CAGR

HPP-P-C

N/A

DRUG

8.42%

Debt to Equity

Winner

HPP-P-C

0.00%

DRUG

0.03%

Free Cash Flow Yield

Winner

HPP-P-C

16.71%

DRUG

-2.01%

P/B Ratio

HPP-P-C

N/A

DRUG

3.49

HPP-P-C vs DRUG - Historical Returns

Returns include dividend reinvestment.

Period	HPP-P-C	DRUG
1 month	-0.77%	+9.46%
3 months	+2.00%	-19.61%
6 months	-2.60%	-18.06%
1 year	+6.09%	+138.59%
5 years(CAGR)	-3.34%	+26.98%
Max(CAGR)	-3.34%	+19.96%

HPP-P-C

-0.77%

Winner

DRUG

+9.46%

Winner

HPP-P-C

+2.00%

DRUG

-19.61%

Winner

HPP-P-C

-2.60%

DRUG

-18.06%

HPP-P-C

+6.09%

Winner

DRUG

+138.59%

5Y(CAGR)

HPP-P-C

-3.34%

Winner

DRUG

+26.98%

Max(CAGR)

HPP-P-C

-3.34%

Winner

DRUG

+19.96%

HPP-P-C vs DRUG - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

Year	HPP-P-C	DRUG
2026	-2.98%	-14.58%
2025	+20.41%	+89.83%
2024	+10.84%	+1859.10%
2023	+18.76%	-63.33%
2022	-47.73%	-78.04%
2021	+5.54%	-41.30%

HPP-P-C vs DRUG Drawdown Comparison

The maximum drawdown for HPP-P-C was -66.52%, occurring on May 12, 2023. This drawdown has not yet recovered.

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The current HPP-P-C drawdown is -19.20%. The current DRUG drawdown is -25.73%.

Rank	HPP-P-C	DRUG
#1	-66.52% Dec 31, 2021 - May 12, 2023	-97.68% Nov 8, 2021 - Oct 18, 2024
#2	-0.89% Dec 22, 2021 - Dec 31, 2021	-58.28% Nov 6, 2024 - Sep 29, 2025
#3	-0.76% Nov 16, 2021 - Nov 24, 2021	-38.35% Jan 7, 2026 - Jun 15, 2026
#4	-0.55% Dec 2, 2021 - Dec 6, 2021	-27.84% Mar 22, 2021 - Aug 24, 2021
#5	-0.47% Dec 14, 2021 - Dec 21, 2021	-26.13% Oct 21, 2025 - Nov 28, 2025
#6	-0.44% Nov 24, 2021 - Nov 29, 2021	-19.30% Dec 16, 2025 - Jan 7, 2026
#7	-0.27% Dec 7, 2021 - Dec 9, 2021	-16.21% Sep 30, 2025 - Oct 9, 2025
#8	-0.24% Nov 29, 2021 - Dec 2, 2021	-14.42% Oct 11, 2021 - Nov 3, 2021
#9	-0.12% Dec 9, 2021 - Dec 13, 2021	-9.05% Oct 24, 2024 - Nov 4, 2024
#10	N/A	-7.65% Oct 14, 2025 - Oct 21, 2025
#11	N/A	-5.42% Dec 11, 2025 - Dec 16, 2025
#12	N/A	-4.62% Sep 24, 2021 - Sep 29, 2021
#13	N/A	-4.59% Dec 8, 2025 - Dec 10, 2025
#14	N/A	-4.38% Aug 24, 2021 - Sep 1, 2021
#15	N/A	-3.81% Sep 1, 2021 - Sep 17, 2021

Correlation

Correlation between HPP-P-C and DRUG is 0.49 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.49

-101